IN2014MN01933A - - Google Patents

Info

Publication number
IN2014MN01933A
IN2014MN01933A IN1933MUN2014A IN2014MN01933A IN 2014MN01933 A IN2014MN01933 A IN 2014MN01933A IN 1933MUN2014 A IN1933MUN2014 A IN 1933MUN2014A IN 2014MN01933 A IN2014MN01933 A IN 2014MN01933A
Authority
IN
India
Prior art keywords
relates
extract
composition
present
effective amount
Prior art date
Application number
Other languages
English (en)
Inventor
Arvind Saklani
Parikshit Gaikwad
Aslam Burhan
Somesh Sharma
Original Assignee
Piramal Entpr Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Piramal Entpr Ltd filed Critical Piramal Entpr Ltd
Publication of IN2014MN01933A publication Critical patent/IN2014MN01933A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/38—Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
IN1933MUN2014 2012-03-13 2013-03-12 IN2014MN01933A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261610002P 2012-03-13 2012-03-13
PCT/IB2013/051925 WO2013136257A1 (en) 2012-03-13 2013-03-12 Herbal composition for the treatment of metabolic disorders

Publications (1)

Publication Number Publication Date
IN2014MN01933A true IN2014MN01933A (ja) 2015-07-10

Family

ID=49160323

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1933MUN2014 IN2014MN01933A (ja) 2012-03-13 2013-03-12

Country Status (13)

Country Link
US (1) US20150050373A1 (ja)
EP (1) EP2825183A4 (ja)
JP (1) JP2015509976A (ja)
KR (1) KR20140138275A (ja)
CN (1) CN104203258A (ja)
AU (1) AU2013233930A1 (ja)
CA (1) CA2866260A1 (ja)
IL (1) IL234616A0 (ja)
IN (1) IN2014MN01933A (ja)
MX (1) MX2014010926A (ja)
NZ (1) NZ630125A (ja)
RU (1) RU2014140852A (ja)
WO (1) WO2013136257A1 (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102393596B1 (ko) 2016-04-22 2022-05-04 리셉터 홀딩스, 인크. 속효성 식물-계 의약 화합물 및 영양 보충제
EA201892396A1 (ru) 2016-12-02 2019-04-30 Ресептор Лайф Сайенсиз, Инк. Быстродействующие растительные лекарственные соединения и биологически активные добавки
US20220214367A1 (en) * 2019-04-15 2022-07-07 Board Of Regents, The University Of Texas System Calibration methods and compositions for biomolecule analysis

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5211944A (en) * 1990-10-12 1993-05-18 Shaman Pharmaceuticals, Inc. Proanthocyanidin polymers having antiviral activity and methods of obtaining same
US6774141B1 (en) * 1992-03-31 2004-08-10 The United States Of America As Represented By The Secretary Of Health And Human Services Calanolide and related antiviral compounds, compositions, and uses thereof
EP0935417B1 (en) * 1996-10-16 2009-05-06 Napo Pharmaceuticals, Inc. Enteric formulations of proanthocyanidin polymer antidiarrheal compositions
US6004996A (en) * 1997-02-05 1999-12-21 Hoffman-La Roche Inc. Tetrahydrolipstatin containing compositions
FR2794973B1 (fr) * 1999-06-18 2001-09-14 Mousny Brigitte Utilisation d'huile de plantes du genre calophyllum extraite a temperature ambiante dans des compositions cosmetiques, dietetiques et therapeutiques
JP2001192317A (ja) * 2000-01-06 2001-07-17 Shiseido Co Ltd マトリックスメタロプロテアーゼ阻害剤
JP2005272326A (ja) * 2004-03-23 2005-10-06 A Pharma Kindai Co Ltd 抗アレルギー剤、抗掻痒剤、及び抗菌剤
FR2886547B1 (fr) * 2005-06-02 2009-06-05 Boucher Claude Henri Marie Ghi Composition cosmetique, dietetique, pharmaceutique obtenue a partir d'huile non raffinee exempte d'acides gras trans, d'esters phorboliques, extraite sans solvant
US8852649B2 (en) * 2006-05-01 2014-10-07 Napo Pharmaceuticals, Inc. Compositions and methods for treating or preventing inflammatory bowel disease, familial adenomatous polyposis and colon cancer
JP2008081440A (ja) * 2006-09-27 2008-04-10 Noevir Co Ltd アロマターゼ活性促進剤
CN101595105B (zh) * 2006-12-20 2013-01-23 诺瓦提斯公司 作为scd抑制剂的2-取代的5元杂环化合物
FR2915095B1 (fr) * 2007-04-17 2013-08-23 Diaye Yacine Isabelle Monique N Creme de soin
WO2010065528A2 (en) * 2008-12-02 2010-06-10 Kreations By Kristin, L.C. Gymnema-containing lip balm compositions and associated methods
US8821948B2 (en) * 2010-03-04 2014-09-02 Steva A. Komeh-Nkrumah Therapeutic, bio-affecting and body treating composition

Also Published As

Publication number Publication date
CA2866260A1 (en) 2013-09-19
NZ630125A (en) 2017-01-27
KR20140138275A (ko) 2014-12-03
RU2014140852A (ru) 2016-05-10
CN104203258A (zh) 2014-12-10
JP2015509976A (ja) 2015-04-02
US20150050373A1 (en) 2015-02-19
EP2825183A4 (en) 2015-09-23
MX2014010926A (es) 2015-04-10
WO2013136257A1 (en) 2013-09-19
IL234616A0 (en) 2014-11-30
EP2825183A1 (en) 2015-01-21
AU2013233930A1 (en) 2014-09-25

Similar Documents

Publication Publication Date Title
MX2014015004A (es) Inhibidores de bromodominio de benzo [c] isoxazoloazepina y sus usos.
WO2014152029A3 (en) Oxazolo[5,4-c]quinolin-2-one compounds as bromodomain inhibitors
MX344521B (es) Aminas heterociclicas y sus usos.
IN2012DN03312A (ja)
PH12014501967A1 (en) Benzodioxanes in combination with other actives for inhibiting leukotriene production
IN2015DN01727A (ja)
IN2014MN02269A (ja)
WO2013055899A3 (en) Compositions useful in treating nephropathy and methods for preparation of same
MX2015000179A (es) Composiciones y formas de dosificacion de itraconazol y metodos de uso de las mismas.
IN2014DN09584A (ja)
IN2014MN01933A (ja)
MX2020001428A (es) Composiciones de grapiprant y metodos para usar las mismas.
GB201307973D0 (en) Extracts of cynanchum SP.and active ingredients contained therein in use of arthritis treatment
EP2799082A4 (en) PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORAL DISEASES OR ASTHMA CONTAINING A STOREM STEREMIA OVALIFOLIA EXTRACT OR A FRACTION OF IT AS AN ACTIVE SUBSTANCE
MY160160A (en) Anti-wart pharmaceutical composition and method for treating wart
EP2596787A4 (en) NEW USE OF HESPERETIN
MX366309B (es) Composicion farmaceutica para el tratamiento de inflamacion y dolor.
BR112014004737A2 (pt) composto de composição de cloridrato de ambroxol e método de preparação do composto
WO2012108748A3 (ko) 합환피 추출물을 포함하는 뇌암 치료용 조성물 및 화장료 조성물
WO2012108747A3 (ko) 토목향 추출물을 포함하는 뇌암 치료용 조성물 및 화장료 조성물
WO2013038200A3 (en) Neurodevelopmental disorders
WO2012162471A3 (en) Pachycereus plant extract and methods of use thereof
WO2012108746A3 (ko) 천초근 추출물을 포함하는 뇌암 치료용 조성물 및 화장료 조성물
WO2012108743A3 (ko) 백축 추출물을 포함하는 뇌암 치료용 조성물 및 화장료 조성물
WO2012108744A3 (ko) 선복화 추출물을 포함하는 뇌암 치료용 조성물 및 건강 기능성 식품